# SURMOUNT-5 Lifetime Cost Model: Tirzepatide Dominant Over Semaglutide

A U.S. cost-effectiveness model built on SURMOUNT-5 projected lifetime costs and health outcomes for tirzepatide and semaglutide.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/tirzepatide-lifetime-cost-model
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# SURMOUNT-5 Lifetime Cost Model: Tirzepatide Dominant Over Semaglutide

Using SURMOUNT-5 data, a U.S. model projected lower lifetime societal costs and more quality-adjusted years with tirzepatide than with semaglutide.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20266 min readUpdated November 2026

Modeled lifetime differences vs semaglutide · $41,688 lower societal costs per patient · 0.506 more quality-adjusted life years

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

A [comparison of treatment cost and benefit](https://buythisglp.com/research/is-tirzepatide-worth-the-extra-cost) depends on the period and whose costs are counted. This simulation used data from the SURMOUNT-5 trial to project lifetime results from a U.S. societal perspective [\[1\]](https://buythisglp.com/research/tirzepatide-lifetime-cost-model#ref-1).

## What the model projected

Compared with semaglutide, tirzepatide was projected to cost $41,688 less per person and yield 0.506 additional quality-adjusted life years. The model also projected 70 fewer cases of type 2 diabetes and 10 fewer cardiovascular disease cases per 1,000 patients [\[1\]](https://buythisglp.com/research/tirzepatide-lifetime-cost-model#ref-1).

The model used changes in weight and other risk factors to estimate later outcomes. It counted health care and wider societal costs, including lost productivity. The trial did not observe those lifetime outcomes.

## Why assumptions and perspective matter

Research on [how long people stay on GLP-1 treatment](https://buythisglp.com/research/how-long-do-people-stay-on-a-glp1) shows why results from one care setting may be difficult to carry over to another. The lifetime estimates depend on the model's treatment, cost and risk assumptions.

The study includes authors affiliated with Eli Lilly, which makes tirzepatide. The projected difference in societal costs cannot be used as an individual prescription quote.

## Frequently asked

Did the trial observe $41,688 in lifetime savings?

That figure came from a simulation using trial inputs. It represents projected societal costs rather than a bill or observed lifetime spending.

## Sources

1.  \[1\] Johansson E, et al. (2026). Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial Journal of Medical Economics. [PMID 42012820](https://doi.org/10.1080/13696998.2026.2646078)

## Where to get it

### The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

[See the board →](https://buythisglp.com/best/cheapest-glp1)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
